Pons Barcons, G. (2024). Inhibition of Mdm2-p53 interaction as a therapeutic strategy for the treatment of p53 wild-type rhabdomyosarcoma.
Citación estilo ChicagoPons Barcons, Guillem. Inhibition of Mdm2-p53 Interaction As a Therapeutic Strategy for the Treatment of P53 Wild-type Rhabdomyosarcoma. 2024.
Cita MLAPons Barcons, Guillem. Inhibition of Mdm2-p53 Interaction As a Therapeutic Strategy for the Treatment of P53 Wild-type Rhabdomyosarcoma. 2024.
Precaución: Estas citas no son 100% exactas.